Internal candidate Clause Samples

Internal candidate. A bargaining unit employee currently employed by the University on a permanent basis.
View SourceView Similar (19)
Internal candidate. An Internal Candidate is a Regular employee who has successfully completed the Probationary Period. Employees who wish to be considered for a posted position must apply by submitting a curriculum vitae and cover letter to ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇ within the internal posting period. After the application of Article 19.1 (b), a Temporary Employee will be considered as an Internal Candidate only for the purpose of application to the posted position for which they were a temporary employee. When the internal posting period is completed, the HR Office will send all of the Internal Candidate applications to the Senior Manager/Delegate and the Search Committee. All internal applications will be reviewed by the Committee. No external applications will be submitted for review during this period. The Search Committee will interview the qualified Internal Candidates. If a suitable Internal Candidate is identified, the Search Committee will make its recommendation to the Senior Manager. When two or more candidates are judged by the Search Committee to equally meet the required qualifications as stated in the job posting, seniority will be the determining factor.
View Source

Related to Internal candidate

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.